Postbiotics JK5G NSCLC feces metagenome Raw sequence reads Metagenome

To evaluate the effect of the postbiotics JK5G on regulating the imbalanced gut microbiota and its impact on the efficacy and incidence rate of immune-related adverse events (irAEs) in non-small-cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs)

本数据集用于评估后生元（postbiotics）JK5G对失衡肠道菌群的调节作用，及其对接受免疫检查点抑制剂（ICIs）治疗的非小细胞肺癌（NSCLC）患者的疗效与免疫相关不良事件（irAEs）发生率的影响。